How cagrilintide targets satiety Cagrilintide operates through a single, highly targeted pathway
GLP-1 or GLP-1R agonists display a diverse range of physiological functions as shown in the image below
In terms of renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria and not on hard kidney endpoints [3, 6, 8]
However, that study was done in only 6 subjects, raising concerns about the lack of statistical power to detect a clinically relevant effect
If You Take Medication for Type 1 Diabetes Does anyone suggest you should just try harder to make your own insulin
But studies of GLP-1 patients have shown that muscle loss also occurs, which for athletes, would do the opposite of enhancing performance